Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes

Diabetes Care

Volumn 25, Issue 8, 2002, Pages 1336-1339

  Desouza, Cyrus ^a   Parulkar, Akhil ^a   Lumpkin, David ^a   Akers, Donald ^a   Fonseca, Vivian A ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL; PIPERAZINE DERIVATIVE; VASODILATOR AGENT;

ADULT; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY OCCLUSION; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; ERECTILE DYSFUNCTION; HEART DISEASE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; ULTRASOUND; BLOOD FLOW; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; IMPOTENCE; MIDDLE AGED; PROSPECTIVE STUDY; VASODILATATION;

ADULT; BRACHIAL ARTERY; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 0036673903     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.8.1336     Document Type: Article

References (16)

1. Lue TF: Erectile dysfunction. N Engl J Med 342:1802-1813, 2000
2. Sullivan ME, Thompson CS, Dashwood MR, Khan MA, Jeremy JY, Morgan RJ, Mikhailidis DP: Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 43:658-665, 1999
3. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
4. Li H, Forstermann U: Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254, 2000
5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516, 1993
6. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA: Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695-1701, 1998
7. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM: Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164-2171, 1998
8. Rendell MS, Rajfer J, Wicker PA, Smith MD: Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial: Sildenafil Diabetes Study Group. JAMA 281:421-426, 1999
9. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
10. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE: Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 74:247-253, 1995
11. Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S: Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 36:845-851, 2000
12. McCullough AR: SRSA: intercourse success rates with sildenafil citrate (Abstract). J Urol 165 (Suppl.):699, 2001
13. Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E: Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. Br Med J 322:651-652, 2001
14. Jackson G: Phosphodiesterase 5 inhibition: effects on the coronary vasculature. Int J Clin Pract 55:183-188, 2001
15. Herrmann HC, Chang G, Klugherz BD, Mahoney PD: Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 342:1622-1626, 2000
16. Calles-Escandon J, Cipolla M: Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36-52, 2001